Business Wire

BYD-AUTO

21.11.2023 02:00:47 CET | Business Wire | Press release

Share
BYD Showcases Full Lineup of New Energy Vehicles at the 21st Guangzhou International Automobile Exhibition

BYD, the world’s leading manufacturer of new energy vehicles, showcased its full lineup of vehicles at the 21st Guangzhou International Automobile Exhibition from November 17th to 26th. BYD featured the global debut of the e⁴ concept car, the release of the Supercar Platform, and the unveiling of the new pure electric SUV—the BYD Sea Lion 07 EV*.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231120172380/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

New concept car of Yangwang (Photo: Business Wire)

Yangwang Unveiled a New e⁴ Concept Car and Supercar Platform

BYD's premium sub-brand Yangwang dazzled with the debut of its latest e⁴ concept car, supercar platform, and brought U8 and U9 to the auto show. The e⁴ concept car by Yangwang lacked traditional steering gear and braking mechanisms. It employed a three-in-one technology for driving, braking, and steering, eliminating the need for conventional mechanical systems. Earlier this year, Yangwang introduced the exclusive Yangwang Architecture for high-end new energy vehicles. The Supercar Platform under this architecture made its official debut, marking Yangwang's transition from the wilderness to the racetrack with cutting-edge technology. At the exhibition, the interior of the Yangwang U9 was unveiled for the first time, showcasing a cockpit that exuded both technological sophistication and sportiness.

Sea Lion 07 EV*: A New Member of the BYD Ocean Series

BYD Ocean Series unveiled its first mid-sized pure electric SUV, the Sea Lion 07 EV*, at the exhibition. Embracing the 'Ocean Aesthetics' design philosophy, it utilized rear-wheel/four-wheel drive architecture, equipped with CTB technology and iTAC intelligent torque control technology. Additionally, it featured front double-wishbone and rear five-link independent suspension, along with the BYD DiSus Intelligent Body Control System. Currently, the Ocean Series boasts several popular models such as the Dolphin, Seal, establishing a robust Ocean Series IP. In the future, the Ocean Series would consolidate SUV models under the intellectual property of Sea Lion* and sedan models under the intellectual property of Seal.

Denza D9 PREMIER (inaugural edition with four seats) Showcased its Intelligent Configurations

Denza, another high-end sub-brand under BYD's diversified brand matrix, presented the D9 PREMIER (inaugural edition with four seats) along with several cutting-edge technologies. The exterior of D9 PREMIER (inaugural edition with four seats) adopted a galaxy dual-tone body, and the interior featured the application of intangible cultural heritage gilding techniques. The cabin was equipped with 22 DEVIALET audio speakers and a premier intelligent customized cockpit, including an 8-inch armrest screen.

In December, high-speed NOA (Navigate on Autopilot) will be rolled out to consumers, followed by the gradual release of urban NOA in Q1 of next year. High-speed NOA-enabled vehicles will be delivered to consumers in December. Additionally, features such as Sentry Mode, Light Map Mode, and Commute Mode will progressively roll out next year.

FANGCHENGBAO and the Stunning BAO 5

BYD's professional personalized sub-brand FANGCHENGBAO also brought its BAO 5 to the exhibition. The BAO 5, which was just launched last week, positioned itself as a "Super Hybrid Hardcore SUV" starting at 289,800 RMB and was equipped with BYD's core technologies such as DMO and DiSus-P. BAO 5 used the ultra-safe blade battery, which adopted a 5-layer protection structure and was shielded by a ring-type double protection system.

BYD had a total of 4 booths at the 21st Guangzhou International Automobile Exhibition, which continued until November 26th. Various of BYD’s hardcore technologies, including the Dual Mode Off-road (DMO) Super Hybrid Platform, BYD DiSus Intelligent Body Control System, and e⁴ Platform also made appearances by some display platforms at this exhibition. BYD demonstrated its pioneer technology and leading advancements, contributing to helping cool the earth by 1℃.

(The product name with the "*" mark in this press release is a translation from the Chinese product name and is currently only applicable for the expressions of models launched in China.)

About BYD

BYD is a multinational high-tech company devoted to leveraging technological innovations for a better life. Founded in 1995 as a rechargeable battery maker, BYD now boasts a diverse business scope covering automobiles, rail transit, new energy, and electronics, with over 30 industrial parks in China, the United States, Canada, Japan, Brazil, Hungary, and India. From energy generation and storage to its applications, BYD is dedicated to providing zero-emission energy solutions that reduce global reliance on fossil fuels. Its new energy vehicle footprint now covers 6 continents, over 70 countries and regions, and more than 400 cities. Listed in both Hong Kong and Shenzhen Stock Exchanges, the company is known to be a Fortune Global 500 enterprise that furnishes innovations in pursuit of a greener world.

For more information, please visit www.bydglobal.com.

About BYD Auto

Founded in 2003, BYD Auto is the automotive subsidiary of BYD, a multinational high-tech company devoted to leveraging technological innovations for a better life. Aiming to accelerate the green transition of the global transportation sector, BYD Auto focuses on developing pure electric and plug-in hybrid vehicles. The company has mastered the core technologies of the entire industrial chain of new energy vehicles, such as batteries, electric motors, and electronic controllers. It has witnessed in recent years significant technological advancements, including the Blade Battery, DM-i Super Hybrid Technology, e Platform 3.0, CTB Technology, e⁴ Platform, BYD DiSus Intelligent Body Control System, and DMO super hybrid system. The company is the world's first carmaker to stop the production of fossil-fueled vehicles on the EV shift and has remained top of new energy passenger vehicle sales in China for 10 years in a row.

For more information, please visit www.byd.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231120172380/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release

The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t

Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release

Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release

News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye